A 28-year-old woman from rural Maharashtra presents with a 3-week history of epigastric pain, early satiety, and nausea. She reports no fever or diarrhea. Upper endoscopy reveals antral gastritis with intestinal metaplasia. Rapid urease test on antral biopsy is positive. Serology shows anti-CagA and anti-VacA antibodies. Which of the following best explains her increased risk of gastric adenocarcinoma?

Explanation

## Helicobacter pylori Pathogenesis and Gastric Cancer Risk ### CagA as the Key Virulence Factor **Key Point:** CagA (cytotoxin-associated gene A) is a bacterial protein injected into host epithelial cells via a Type IV secretion system, where it undergoes tyrosine phosphorylation and disrupts cell adhesion molecules, particularly E-cadherin. **High-Yield:** CagA-positive strains are strongly associated with: - Chronic active gastritis - Intestinal metaplasia - Gastric adenocarcinoma (especially diffuse type) - MALT lymphoma ### Mechanism of Malignant Transformation 1. **CagA translocation** → phosphorylation by Src kinase in epithelial cells 2. **Loss of E-cadherin** → disruption of cell-cell adhesion 3. **Activation of Wnt/β-catenin signaling** → increased cell proliferation 4. **Chronic inflammation** → oxidative stress and DNA damage 5. **Intestinal metaplasia** → field effect for dysplasia ### VacA's Role (Distinct from CagA) **Clinical Pearl:** VacA (vacuolating cytotoxin A) causes vacuolation of epithelial cells and apoptosis, but does NOT directly trigger the adhesion-molecule disruption seen with CagA. VacA contributes to inflammation but is secondary to CagA in malignant transformation. ### Comparison of H. pylori Virulence Factors | Factor | Mechanism | Clinical Significance | | --- | --- | --- | | **CagA** | Type IV secretion; phosphorylation; E-cadherin loss | Gastric cancer, MALT lymphoma | | **VacA** | Vacuolation; apoptosis; IL-8 induction | Gastritis; less specific for cancer | | **Urease** | Ammonia production; acid neutralization | Survival in gastric pH; not oncogenic | | **Flagella** | Motility; chemotaxis | Colonization; not directly oncogenic | **Mnemonic:** **CagA = Cancer-Associated Gene A** — remember that CagA is the oncogenic protein. ### Why This Patient Has Elevated Cancer Risk The presence of **anti-CagA antibodies** indicates infection with a CagA-positive strain. Combined with evidence of intestinal metaplasia on endoscopy, she has crossed into the **Correa cascade** (chronic gastritis → atrophic gastritis → intestinal metaplasia → dysplasia → adenocarcinoma). CagA-positive H. pylori accelerates this progression.